Quick Answer
NEKTAR THERAPEUTICS reported Common Stock Shares Outstanding of 20.38 million shares for the year ending 2025.
- NEKTAR THERAPEUTICS showed an increase of +64.5% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from NEKTAR THERAPEUTICS's annual report (Form 10-K), filed with the SEC on March 13, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 16 years of available data (2010 to 2025), NEKTAR THERAPEUTICS's Common Stock Shares Outstanding has declined by 78.4%.
- Historical annual values: Fiscal year 2025: 20.38 million shares | Fiscal year 2024: 12.39 million shares | Fiscal year 2023: 191.38 million shares | Fiscal year 2022: 188.56 million shares | Fiscal year 2021: 185.47 million shares | Fiscal year 2020: 180.09 million shares | Fiscal year 2019: 176.51 million shares | Fiscal year 2018: 173.53 million shares | Fiscal year 2017: 159.52 million shares | Fiscal year 2016: 153.21 million shares | Fiscal year 2015: 135.29 million shares | Fiscal year 2014: 131.22 million shares | Fiscal year 2013: 116.49 million shares | Fiscal year 2012: 115.26 million shares | Fiscal year 2011: 114.49 million shares | Fiscal year 2010: 94.52 million shares.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: